Literature DB >> 12388326

Isolation of interstitial fluid from rat mammary tumors by a centrifugation method.

Helge Wiig1, Knut Aukland, Olav Tenstad.   

Abstract

Access to interstitial fluid is of fundamental importance to understand tumor transcapillary fluid balance, including the distribution of probes and therapeutic agents. Tumors were induced by gavage of 9,10-dimethyl-1,2-benzanthracene to rats, and fluid was isolated after anesthesia by exposing tissue to consecutive centrifugations from 27 to 6,800 g. The observed (51)Cr-EDTA (extracellular tracer) tissue fluid-to-plasma ratio obtained from whole tumor or from superficial tumor tissue by centrifugation at 27-424 g was not significantly different from 1.0 (0.92-0.99), suggesting an extracellular origin only. However, fluid collected from excised central tumor parts had a significantly lower ratio (0.66-0.77) for all imposed G forces, suggesting dilution by fluid deriving from a space unavailable for (51)Cr-EDTA. The colloid osmotic pressure in tumor fluid was generally higher than in fluid isolated from the subcutis, attributable to less selective capillaries and impaired lymphatic drainage in tumors. HPLC analysis of tumor fluid showed that low-molecular-weight macromolecules not present in arterial plasma were present in tumor fluid obtained by centrifugation and in venous blood draining the tumor, most likely representing proteins derived from tumor cells. We conclude that low-speed centrifugation may be a simple and reliable method to isolate interstitial fluid from tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388326     DOI: 10.1152/ajpheart.00327.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  42 in total

1.  Compartmental tissue distribution of antibody therapeutics: experimental approaches and interpretations.

Authors:  C Andrew Boswell; Daniela Bumbaca; Paul J Fielder; Leslie A Khawli
Journal:  AAPS J       Date:  2012-05-31       Impact factor: 4.009

Review 2.  In vitro microfluidic models of tumor microenvironment to screen transport of drugs and nanoparticles.

Authors:  Altug Ozcelikkale; Hye-Ran Moon; Michael Linnes; Bumsoo Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-14

Review 3.  The Tumor Metabolic Microenvironment: Lessons from Lactate.

Authors:  Juan C García-Cañaveras; Li Chen; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2019-06-06       Impact factor: 12.701

4.  The interstitial distribution of macromolecules in rat tumours is influenced by the negatively charged matrix components.

Authors:  Helge Wiig; Christina C Gyenge; Olav Tenstad
Journal:  J Physiol       Date:  2005-06-30       Impact factor: 5.182

5.  Pathophysiology of tissue fluid accumulation in inflammation.

Authors:  Helge Wiig
Journal:  J Physiol       Date:  2011-04-11       Impact factor: 5.182

6.  Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

Authors:  Miro J Eigenmann; Tine V Karlsen; Ben-Fillippo Krippendorff; Olav Tenstad; Ludivine Fronton; Michael B Otteneder; Helge Wiig
Journal:  J Physiol       Date:  2017-10-29       Impact factor: 5.182

7.  Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.

Authors:  Masayuki Nagahashi; Akimitsu Yamada; Hiroshi Miyazaki; Jeremy C Allegood; Junko Tsuchida; Tomoyoshi Aoyagi; Wei-Ching Huang; Krista P Terracina; Barbara J Adams; Omar M Rashid; Sheldon Milstien; Toshifumi Wakai; Sarah Spiegel; Kazuaki Takabe
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-05-19       Impact factor: 2.673

8.  Interstitial fluid: the overlooked component of the tumor microenvironment?

Authors:  Helge Wiig; Olav Tenstad; Per Ole Iversen; Raghu Kalluri; Rolf Bjerkvig
Journal:  Fibrogenesis Tissue Repair       Date:  2010-07-23

9.  Differential cytokine response in interstitial fluid in skin and serum during experimental inflammation in rats.

Authors:  Torbjørn Nedrebø; Rolf K Reed; Roland Jonsson; Ansgar Berg; Helge Wiig
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

Review 10.  High shed antigen levels within tumors: an additional barrier to immunoconjugate therapy.

Authors:  Yujian Zhang; Ira Pastan
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.